CCX733 is a selective CXCR7 antagonist that reduces the antiapoptotic effects of CXCL12 in glioma cells (Hattermann et al., 2010) and CXCR7-induced EMT in bladder cancer (Hao et al., 2012). This evidence concerns the gene CXCL12 and urinary bladder cancer.